Cell cycle distribution of hypoxia and progression of hypoxic tumour cells in vivo

British Journal of Cancer

Volumn 77, Issue 2, 1998, Pages 227-234

  Webster, L ^a   Hodgkiss, R J ^b   Wilson, G D ^c  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

^c NONE

Author keywords

Cell cycle; Hypoxia; Multi parameter flow cytometry; Proliferation; Tumour

Indexed keywords

BROXURIDINE; PROPIDIUM IODIDE; THEOPHYLLINE DERIVATIVE;

ANEUPLOIDY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL HYPOXIA; CELL PROLIFERATION; FLOW CYTOMETRY; MITOSIS; MOUSE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; SARCOMA; TUMOR CELL LINE;

EID: 0031964536     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.38     Document Type: Article

References (39)

1. Amellem O and Pettersen EO (1991) Cell inactivation and cell cycle inhibition as induced by extreme hypoxia: the possible role of cell cycle arrest as a protection against hypoxia-induced lethal damage. Cell Prolif 24: 127-141
2. Begg AC, McNally NJ, Shrieve DC and Karcher H (1985) A method to measure the DNA synthesis and the potential doubling time from a single sample. Cytometry 6: 620-626
3. Begg AC, Holland I, van Glabekke M, Bartelink H and Horiot JC (1992) Predictive value of potential doubling time for radiotherapy of head and neck tumour patients: results from the EORTC co-operative trial 22851. Semin Rad Oncol 2: 22-25
4. Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR and Dewhirst MW (1996) Tumour oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56: 941-943
5. Corvo R, Giaretti W, Sanguineti G, Geido H, Orecchia R, Guenzi M, Margarino G, Bacigalupo A, Garaventa G, Barbieri M and Vitale V (1995) In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen. J Clin Oncol 13: 1843-1850
6. Cox LS and Lane DP (1995) Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage. Bioessays 17: 501-508
7. Denekamp J, Hirst DG, Stewart FA and Terry NH (1980) Is tumour radiosensitization by misonidazole a general phenomenon? Br J Cancer 41: 1-9
8. 31P NMR spectroscopy measurements, tumour size, hypoxic fraction and cell survival after radiotherapy. Int J Rad Oncol Biol Phys 18: 1341-1350
9. Gelfant S (1977) A new concept of tissue and tumour cell proliferation. Cancer Res 37: 3845-3862
10. Graeber TG, Peterson JF, Tsai M, Monica K, Fornace AJ Jr and Giaccia AJ (1994) Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol 14: 6264-6277
11. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW and Giaccia AJ (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours (see comments). Nature 379: 88-91
12. Gray LH, Conger AD, Ebert M, Hornsey S and Scott OCA (1953) The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 26: 638-648
13. Hewitt HB and Wilson CW (1961) Survival curves for tumour cells irradiated in vitro. Ann NY Acad Sci 95: 818-827
14. Hewitt HB, Blake E and Porter EH (1973) The effect of lethally irradiated cells on the transplantability of murine tumours. Br J Cancer 28: 123-135
15. Hirst DG and Denekamp J (1979) Tumour cell proliferation in relation to the vasculature. Cell Tissue Kinet 12: 31-42
16. Hodgkiss RJ, Jones G, Long A, Parrick J, Smith KA, Stratford MRL and Wilson GD (1991) Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection. Br J Cancer 63: 119-125
17. Hodgkiss RJ, Stratford MRL, Dennis MF and Hill SA (1995) Pharmacokinetics and binding of the bioreductive probe for hypoxia, NITP: effect of route of administration. Br J Cancer 72: 1462-1468
18. Moulder JE and Rockwell S (1984) Hypoxic tractions of solid tumours: experimental techniques, methods of analysis and a survey of existing data. Int J Rad Oncol Biol Phys 10: 695-712
19. Nordsmark M, Hoyer M, Keller J, Nielsen OS, Jensen OM and Overgaard J (1996) Int J Rad Oncol Biol Phys 35: 701-708
20. 31P NMR for non-invasive evaluation of tumour metabolic status. Int J Rad Oncol Biol Phys 12: 793-79
21. Overgaard J (1992) Importance of tumour hypoxia in radiotherapy: a meta-analysis of controlled clinical trials. Radiother Oncol 24: S64
22. Pallavicini MG, Lalande ME, Miller RG and Hill RP (1979) Cell cycle distribution of chronically hypoxic cells and determination of the clonogenic potential of cells accumulated in G2+M phases after irradiation of a solid tumour in vivo. Cancer Res 38: 1891-1897
23. Pettersen EO and Lindmo T (1983) Inhibition of cell cycle progression by acute treatment with various degrees of hypoxia: modifications induced by low concentrations of misonidazole present during hypoxia. Br J Cancer 48; 809-817
24. Shimamura A and Fisher DE (1996) p53 in life and death. Clin Cancer Res 2: 435-440
25. Shrieve DC and Begg AC (1985) Cell cycle kinetics of aerated, hypoxic and reaerated cells in vitro using flow cytometric determination of cellular DNA and incorporated bromodeoxyuridine. Cell Tissue Kinet 18: 641-651
26. Siemann DW (1980) Tumour size: a factor influencing the isoeffect analysis of tumour response to combined modalities. Br J Cancer 42 (suppl. 4): 294-298
27. Siemann DW and Keng PC (1988) Characterisation of radiation resistant hypoxic cell subpopulations in KHT sarcomas. II. Cell sorting. Br J Cancer 58: 296-300
28. Spiro IJ, Rice GC, Durand RE, Stickler R and Ling CC (1984) Cell killing, radiosensitization and cell cycle redistribution induced by chronic hypoxia. Int J Rad Oncol Biol Phys 10: 1275-1280
29. Stanely JA, Shipley WU and Steel GG (1977) Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour. Br J Cancer 36: 105-113
30. Stewart N, Hicks GG, Paraskevas F and Mowat M (1995) Evidence for a second cell cycle block at G2/M by p53. Oncogene 10: 109-116
31. Stone HB, Brown JM, Phillips TL and Sutherland RM (1993) Oxygen in human tumours: correlations between methods of measurement and response to therapy. Rad Res 136: 422-434
32. Sutherland RM, Sordat B, Bamat J, Gabbert H, Bourrat B and Mueller-Klieser W (1986) Oxygenation and differentiation in multicellular spheroids of human colon carcinoma. Cancer Res 46: 5320-5329
33. Tannock IF (1968) The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour. Br J Cancer 22: 258-273
34. Wallen CA, Michaelson SM and Wheeler KT (1980) Evidence for an unconventional radiosensitivity of rat 9L subcutaneous tumours. Rad Res 84: 529-541
35. Webster L, Hodgkiss RJ and Wilson GD (1995) Simultaneous triple staining for hypoxia, proliferation and DNA content in solid murine tumours. Cytometry 21: 344-351
36. Wilson GD, McNally NJ, Dische S, Saunders MI, Des Rochers C, Lewis AA and Bennet MH (1988) Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer 58: 423-431
37. Wilson GD, McNally NJ, Dunphy E, Karcher H and Pfragner R (1985) The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry. Cytometry 6: 641-647
38. Wilson GD, Martindale CA, Soranson JA, Bourhis J, Carl UM and McNally NJ (1994) Radiation-induced cell cycle delay measured in two mouse tumours in vivo using bromodeoxyuridine. Rad Res 137: 177-185
39. Zeman EM, Calkins DP, Cline JM, Thrall DE and Raleigh JA (1993) The relationship between proliferate and oxygenation status in spontaneous canine tumours. Int J Radiat Oncol Biol Phys 27: 891-898